Search

Pomalidomide prolongs survival in refractory myeloma patients

MM-003 is a large, multi-centre phase 3 study that assessed the efficacy and safety of a new drug, Pomalidomide (POM) in combination with low-dose dexamethasone (POM+LoDex) and compared this combination with high dose dexamethasone in MM patients with late stage…

Read more

Press release: 18th Congress of the European Hematology Association in Stockholm, Sweden June 13-16-2013

The EHA-theme of the year, from June 2013 to June 2014, is dedicated to “Age and Aging in blood disorders”.

Read more

EHA Mentorship Program eligibility

Before applying for the EHA Mentorship Program, please consider the eligibility criteria on this page. You should also read our policy on life events.

Read more

How can I start contributing?

Getting started is easy! Here are a few good-to-know tips, that will help you navigate the different aspects of the EHA Hub.

Read more

What to expect

FacultyThe faculty is made up of international leaders in clinical hematology research, statisticians, experts in regulatory and ethical aspects of clinical research and more.

Read more

In Memoriam Anneke Brand

Picture: Ineke Oostveen

 

On Sunday, November 21, 2021, Anneke Brand, MD, PhD, emeritus professor at Leiden University Medical Center (LUMC), passed away suddenly. The European Hematology Association community is deeply saddened by Anneke’s passing.

Read more

In Memoriam Pieter Van Vlierberghe

 

We are deeply saddened to announce that Pieter Van Vlierberghe (42) has passed away.

Read more